Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - INTERLEUKIN GENETICS INC | Financial_Report.xls |
| 10-Q - EXHIBIT 10-Q - INTERLEUKIN GENETICS INC | v358916_10q.htm |
| EX-3.1 - EXHIBIT 3.1 - INTERLEUKIN GENETICS INC | v358916_ex3-1.htm |
| EX-31.2 - EXHIBIT 31.2 - INTERLEUKIN GENETICS INC | v358916_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - INTERLEUKIN GENETICS INC | v358916_ex31-1.htm |
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED STATES CODE)
(SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED STATES CODE)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18 United States Code), each of the undersigned officers of Interleukin Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report of Form 10-Q for the quarter ended September 30, 2013 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 14, 2013 | /s/ Kenneth S. Kornman |
| | Kenneth S. Kornman |
| | Chief Executive Officer |
| | |
| Date: November 14, 2013 | /s/ Eliot M. Lurier |
| | Eliot M. Lurier |
| | Chief Financial Officer |